6 ms·
The 'risk' here is often carried by publicly funded research. ~6.2 billion for glp The private 'investment' comes in manufacturing, scale and marketing. Novo
by AvocadoPanic 8mo ago
The 'risk' here is often carried by publicly funded research. ~6.2 billion for glp
The private 'investment' comes in manufacturing, scale and marketing.
Novo Nordisk has spent 41% more on shareholder enrichment (buybacks and dividends) than on R&D over the past five years.
- 15155 8mo ago> Novo Nordisk has spent 41% more on shareholder enrichment (buybacks and dividends) than on R&D over the past five years. So they are good stewards of their funds and know they can't deploy as much as they have? Berkshire Hathaway does the same thing.
- AvocadoPanic 8mo agoIs Berkshire Hathaway able to monitize the output of government funded research as effectively?
- deleted 8mo ago[deleted]